Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems

135Citations
Citations of this article
164Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nowadays, the society is facing a large health problem with the rising of new diseases, including cancer, heart diseases, diabetes, neurodegenerative diseases, and obesity. Thus, it is important to invest in substances that enhance the health of the population. In this context, epigallocatechin gallate (EGCG) is a flavonoid found in many plants, especially in tea. Several studies support the notion that EGCG has several benefits in fighting cancer, heart diseases, diabetes, and obesity, among others. Nevertheless, the poor intestinal absorbance and instability of EGCG constitute the main drawback to use this molecule in prevention and therapy. The encapsulation of EGCG in nanocarriers leads to its enhanced stability and higher therapeutic effects. A comprehensive review of studies currently available on the encapsulation of EGCG by means of nanocarriers will be addressed.

Cite

CITATION STYLE

APA

Granja, A., Frias, I., Neves, A. R., Pinheiro, M., & Reis, S. (2017). Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems. BioMed Research International. Hindawi Limited. https://doi.org/10.1155/2017/5813793

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free